More recently, on July 9, 2001, a letter from the current Secretary of Health and Human Services, Tommy Thompson, indicated that based on an analysis by the Food and Drug Administration on the safety issues and analysis by his planning office on the cost issues, he could not make the required determinations, and he stated his view that we should not sacrifice public safety for uncertain speculative cost savings. Secretary Thompson also indicated that prescription drug safety could not be adequately guaranteed if drug reimportation were allowed and that costs associated with documentation, sampling, and testing of imported drugs would make it difficult for consumers to get any significant price savings.
Thad Cochran: “More recently, on July 9, 2001, a letter from the current Secretary of Health and Human Services, Tommy Thompson…”
Editor's note · Context
Discussing a letter from Secretary of Health and Human Services regarding drug reimportation and public safety.
Share
More from Thad Cochran
I wish to honor former Senator Pete V. Domenici of New Mexico, who passed away September 13 in Albuquerque. It was a privilege to call Pete a friend and to work with him as a Senate colleague and member of the Appropriations Committee…
I am concerned that the 22 percent funding cut proposed for NIH could negatively affect longstanding research endeavors.
I understand that the Army's unfunded requirements list includes a $3.1 billion increase in end strength beyond the fiscal year 2017 NDAA mandate.
Could you tell us more about the telehealth services you offer and some of the successes the University of Mississippi in particular, has experienced through telehealth.





